Added to YB: 2026-01-02
Pitch date: 2025-12-25
TMDX [bullish]
TransMedics Group, Inc.
-3.84%
current return
Author Info
No bio for this author
Company Info
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
Market Cap
$4.2B
Pitch Price
$126.51
Price Target
N/A
Dividend
N/A
EV/EBITDA
33.72
P/E
48.97
EV/Sales
7.59
Sector
Health Care Equipment and Supplies
Category
growth
Uncle 2026 TOP 10 High-Growth - TransMedics Group, Inc.
TMDX: Blue ocean MedTech revolutionizing organ transplant w/ proprietary Organ Care System keeping hearts/lungs/liver alive outside body during transport via own aircraft fleet. Sells transportation services not just machines, completely untapped market transforming healthcare standards.
Read full article (1 min)